Driving Impairment

The use of illicit drugs can lead to problems associated with use, including driving while impaired.  Driving while impaired leads to an increased risk of traffic crashes.  PIRE research has shown how law enforcement agencies can detect illicit drug use among drivers.

The Drug Evaluation and Classification (DEC) Program, funded by National Highway Traffic Safety Administration (NHTSA) and managed by PIRE, uses standardized evaluations and drug tests (urinalysis and blood) to identify drivers under the influence of illicit drugs. Trained law enforcement officers - Drug Recognition Experts (DREs) - evaluate suspects who are believed to be under the influence of drugs, but who do not have a sufficiently high blood alcohol content to justify a charge of driving under the influence of alcohol. DREs are trained to detect depressants, stimulants, hallucinogens, PCP, narcotics, inhalants, and cannabis (marijuana).

In addition, PIRE research has also shown that the use of "club drugs," including ecstasy, Ketamine, GHB, and Rohypnol, can lead to traffic crashes.


The items below are selected from the PIRE Resource Finder, which you can search for more publications, staff, etc., on any aspect of this topic.

Published Literature
Previous  Next  All
Staff Experts
PIRE Projects


 

PIRE Resource Finder
Site Map